SLC5A2 and diabetes mellitus: Our model predicts that the natriuretic and diuretic effects of SGLT2 inhibition are reduced but maintained in normoglycemia compared to diabetes, and with renal impairment compared to normal renal function, which is consistent with recent simulations by Layton and Vallon [11].